Provided by Tiger Trade Technology Pte. Ltd.

LANGAR GLOBAL HEALTHTECH ETF

10.35
+0.20502.02%
Volume:2K
Turnover:16.94K
Market Cap:2.38M
PE:- -
High:10.35
Open:10.23
Low:10.23
Close:10.15
52wk High:11.01
52wk Low:7.97
Shares:230.00K
Float Shares:230.00K
Volume Ratio:0.36
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.91
ROE:--
ROA:--
PB:--
PE(LYR):5.43

Loading ...

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

ResMed’s New OSA Diagnostic Study Signals Next Wave in Home Sleep Testing

TIPRANKS
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Moderna Moves Back Toward Covid-Era Valuation with Latest mRNA Update

Dow Jones
·
Aug 19

Moderna : RBC Raises Target Price to $130 from $45

THOMSON REUTERS
·
Aug 19